Camp4 Therapeutics Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Josh Mandel-Brehm
Chief executive officer
US$696.3k
Total compensation
| CEO salary percentage | 78.4% |
| CEO tenure | 8yrs |
| CEO ownership | 1.4% |
| Management average tenure | 3.5yrs |
| Board average tenure | 8yrs |
Recent management updates
No updates
Recent updates
No updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$52m |
| Jun 30 2024 | n/a | n/a | -US$50m |
| Mar 31 2024 | n/a | n/a | -US$50m |
| Dec 31 2023 | US$696k | US$546k | -US$49m |
Compensation vs Market: Josh's total compensation ($USD696.28K) is about average for companies of similar size in the US market ($USD650.40K).
Compensation vs Earnings: Insufficient data to compare Josh's compensation with company performance.
CEO
Josh Mandel-Brehm (41 yo)
8yrs
Tenure
US$696,281
Compensation
Mr. Joshua Mandel-Brehm, also known as Josh, serves as an Independent Director at ProMIS Neurosciences, Inc. September 2021 and served as its Director since September 1, 2021. He has also been a founder an...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 8yrs | US$696.28k | 1.35% $ 1.0m | |
| Founder & Independent Director | no data | US$142.50k | 0.77% $ 579.2k | |
| Chief Financial Officer | no data | US$628.83k | 0.31% $ 231.2k | |
| Chief Scientific Officer & Senior Vice President of Research | 4.8yrs | US$501.93k | 0.31% $ 230.9k | |
| Founder | no data | no data | no data | |
| Chief Business Operations Officer & SVP of Portfolio Strategy & Business Operations | no data | no data | no data | |
| Senior VP & Chief People Officer | 3.5yrs | no data | no data | |
| Senior Vice President of Technical Operations | 2.3yrs | no data | no data | |
| VP & Head of Discovery | no data | no data | no data | |
| Chief Medical Officer | 1.4yrs | no data | 0% $ 0 |
3.5yrs
Average Tenure
47yo
Average Age
Experienced Management: CAMP's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 8yrs | US$696.28k | 1.35% $ 1.0m | |
| Founder & Independent Director | 9yrs | US$142.50k | 0.77% $ 579.2k | |
| Independent Chairman of the Board | 5.3yrs | US$125.00k | 0.54% $ 407.5k | |
| Chairman of Scientific Advisory Board | 5.3yrs | no data | no data | |
| Independent Director | 10yrs | no data | 0% $ 0 | |
| Independent Director | 8yrs | US$42.50k | 0.14% $ 107.5k | |
| Independent Director | 5.7yrs | US$42.50k | 0.10% $ 75.7k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
8.0yrs
Average Tenure
62yo
Average Age
Experienced Board: CAMP's board of directors are considered experienced (8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/15 15:54 |
| End of Day Share Price | 2025/01/15 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Camp4 Therapeutics Corporation is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Eric Joseph | J.P. Morgan |
| Mani Foroohar | Leerink Partners LLC |
| Edward Tenthoff | Piper Sandler Companies |